This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
T. Rowe Price (TROW) to Post Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
T. Rowe's (TROW) Q421 results are likely to reflect revenue growth and unfavorable impacts of net outflows.
T. Rowe Price (TROW) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
T. Rowe (TROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BEN or TROW: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BEN vs. TROW: Which Stock Is the Better Value Option?
Victory Capital (VCTR) Closes the Buyout of WestEnd Advisors
by Zacks Equity Research
Victory Capital's (VCTR) successful closure of the buyout of WestEnd will add capabilities of growth and diversification.
T. Rowe Price (TROW) Wraps Up Buyout of Oak Hill Advisors
by Zacks Equity Research
To expand its expertise in the alternative credit markets, T. Rowe Price (TROW) closes its previously announced buyout of Oak Hill Advisors.
Charles Schwab (SCHW) to Tap T Rowe's (TROW) NTF Funds
by Zacks Equity Research
Charles Schwab (SCHW) partners with T. Rowe Price (TROW) to gain no-transaction-fee access to the least-expensive share class mutual funds offered by the latter.
Virtus Investment (VRTS) November AUM Down 1.5% Sequentially
by Zacks Equity Research
Virtus Investment's (VRTS) November AUM is down 1.5% to $184.5 billion due to lower open-end and closed-end funds' balances.
Victory Capital (VCTR) November AUM Down Sequentially to $160.5B
by Zacks Equity Research
Victory Capital's (VCTR) November AUM down sequentially to $160.5 billion on lower AUM in fixed income, U.S. Mid Cap equity and U.S. Large Cap equity asset classes.
Lazard's (LAZ) November AUM Falls on Market Depreciation
by Zacks Equity Research
Lazard's (LAZ) November AUM is down 4.4% to $267.4 billion due to market depreciation, lower fixed income and equity asset balances.
Franklin's (BEN) November AUM Dips Sequentially to $1,561.7B
by Zacks Equity Research
Franklin's (BEN) November AUM declines 0.95% sequentially to $1,546.8 billion due to the negative impacts of markets, offset by long-term net inflows. This will likely affect its financials.
T. Rowe Price (TROW) November AUM Down 2.6% on Unfavorable Markets
by Zacks Equity Research
T. Rowe Price (TROW) witnesses a 2.6% sequential decline in preliminary assets under management for November 2021.
ATCO or TROW: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ATCO vs. TROW: Which Stock Is the Better Value Option?
ATCO vs. TROW: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ATCO vs. TROW: Which Stock Is the Better Value Option?
Victory Capital (VCTR) October AUM Up Sequentially to $162.6B
by Zacks Equity Research
Victory Capital's (VCTR) October AUM rises 1.7%, sequentially, to $162.6 billion on higher equity asset class balances. This will likely support its financials.
T. Rowe Price's (TROW) October AUM Up 3.7% on Upbeat Markets
by Zacks Equity Research
Efforts to boost operations through planned strategies and rising AUM balance will continue supporting T. Rowe Price's (TROW) financials.
Franklin's (BEN) October AUM Rises 2.1% on Favorable Markets
by Zacks Equity Research
Steadily improving AUM balance and inorganic expansion efforts are likely to keep supporting Franklin's (BEN) financials.
AMG vs. TROW: Which Stock Is the Better Value Option?
by Zacks Equity Research
AMG vs. TROW: Which Stock Is the Better Value Option?
T. Rowe Price (TROW) Q3 Earnings Beat on Higher Revenues
by Zacks Equity Research
T. Rowe Price's (TROW) Q3 earnings reflect solid revenues and higher expenses.
T. Rowe Price (TROW) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
T. Rowe (TROW) delivered earnings and revenue surprises of -1.21% and -0.86%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
T. Rowe Price (TROW) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes? Let's find out.
Will Decline in AUM Hurt T. Rowe Price's (TROW) Q3 Earnings?
by Zacks Equity Research
T. Rowe's (TROW) Q3 results are likely to reflect the unfavorable impact of net outflows and elevated expenses.
Top Analyst Reports for Edwards Lifesciences, DexCom & Twitter
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including Edwards Lifesciences Corporation (EW), DexCom, Inc. (DXCM), and Twitter, Inc. (TWTR).
This is Why T. Rowe Price (TROW) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes? Let's find out.
AMG or TROW: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AMG vs. TROW: Which Stock Is the Better Value Option?
Zacks.com featured highlights include: T. Rowe Price, Best Buy, Celanese Corp, CBRE Group and Regeneron Pharma
by Zacks Equity Research
Zacks.com featured highlights include: T. Rowe Price, Best Buy, Celanese Corp, CBRE Group and Regeneron Pharma